MS20 20mg*10vials

MOTS-c MS20 20mg x 10 Vials

Product Overview

MOTS-c MS20 is a high-concentration formulation in the MOTS-c mitochondrial metabolic peptide series, representing an upgraded version from the basic MS10 and mid-range MS15 formulations. As a highly active endogenous short-chain peptide encoded by mitochondrial open reading frames, it exhibits zero immunogenicity, high biocompatibility, and a unique exercise-mimicking biological mechanism. The 20mg high-concentration dose supports AMPK core energy pathway activation and mTOR signaling regulation, exceeding the efficacy range of low-to-medium dose MOTS-c variants. MS20 supports research in glucose and lipid metabolism remodeling, visceral fat breakdown, insulin resistance intervention, mitochondrial oxidative inflammation elimination, and senescent cell clearance. It is designed for metabolic syndrome modeling, refractory insulin resistance intervention, high-load mitochondrial damage repair, anti-aging mechanism studies, and complex peptide synergistic metabolic regeneration validation, serving as an advanced preclinical research material for mitochondrial physiology, metabolic pharmacology, and degenerative aging research.

Core Research Functions

Exercise-Mimicking Metabolic Activation: Supports simulated exercise-based metabolic activation research and metabolic inertia intervention studies.

Insulin Sensitivity and Glucose Homeostasis: Supports insulin sensitivity enhancement research and blood glucose homeostasis stabilization studies.

Visceral and Liver Fat Breakdown: Supports visceral and liver fat breakdown research and disordered lipid metabolism optimization studies.

Mitochondrial Oxidative Stress and Inflammation Elimination: Supports mitochondrial oxidative stress and chronic inflammation elimination research.

Senescent Cell Clearance: Supports senescent cell comprehensive elimination and deep degenerative aging process intervention research.

MS20 20mg exceeds the basic and medium-dose intensive intervention ranges of MS10 and MS15, supporting high-amplitude experimental phenotype generation, long-lasting stable efficacy output, and comprehensive physiological homeostasis reset research. It targets research on severe refractory metabolic disorders, deep mitochondrial dysfunction, and late-stage age-related degenerative diseases that show limited response to conventional low-to-medium dose regimens. It supports research on severe metabolic syndrome intervention caused by high-fat diet, liver lipid deposit and visceral fat accumulation clearance, and exercise endurance and cellular energy circulation efficiency enhancement. It also supports mitochondrial function deep reconstruction, accumulated free radical elimination, persistent chronic low-grade inflammation intervention, and neuroprotective and anti-aging effect research, providing high-precision, reproducible data for advanced mitochondrial metabolic anti-aging research.

Key Advantages

High-Concentration Mitochondrial Pathway Activation: The 20mg concentration supports AMPK energy-sensing pathway saturation activation research, mitochondrial biosynthesis enhancement, and cellular energy conversion efficiency improvement that exceeds the metabolic efficacy range of the MS10 and MS15 versions.

Enhanced Metabolic Corrective Efficacy: Possesses insulin resistance intervention and glucose and lipid reshaping capabilities, supporting severe refractory metabolic disorder improvement research that exceeds low-or medium-dose regimen response ranges, representing the advanced range of MOTS-c peptide metabolic regulatory efficacy.

Five-Dimensional Synergistic Physiological Optimization: Integrates exercise-simulated fat burning, blood glucose stabilization, lipid deposition intervention, mitochondrial antioxidant and anti-inflammatory effects, and anti-aging and senescent cell clearance, providing comprehensive physiological homeostasis reset research capabilities.

Mitochondrial Function and Energy Metabolism Support: Supports mitochondrial biosynthesis repair research, mitochondrial function deep reconstruction in multiple organs, and systemic energy circulation efficiency enhancement under high metabolic stress conditions.

High-Purity Process and Quality Control: Employs upgraded ultra-fine multi-level deep gradient purification and full-vacuum lyophilization technology, preserving active molecular structure with minimal impurity interference and high-purity experimental variables, ensuring accurate and reproducible research conclusions. Packaged as 10 vials per dust-free aseptic pack, fully tested for purity by HPLC, and accompanied by a complete Certificate of Analysis (COA), suitable for high-standard advanced laboratory research and premium bulk custom procurement.

Specifications and Quality Control

Format: Lyophilized powder, 20mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).